10 drugmakers with highest direct-to-consumer ad spending in 2016

The pharmaceutical industry spent 9 percent more on direct-to-consumer ads in 2016 than in the year prior, with total spending reaching $5.6 billion, according to a Medical Marketing & Media report.

Advertisement

For the report, researchers analyzed Nielsen data on television, magazine, radio, newspaper, business-to-business, outdoor and cinema media spend. The analysis did not include digital spend.

Here are the 10 drugmakers that spent the most on direct-to-consumer ads in 2016, according to the report.

1. Pfizer — $1.19 billion

2. Bristol-Myers Squibb — $458 million

3. AbbVie — $433 million

4. Eli Lilly — $414 million

5. Allergan — $352 million

6. Johnson & Johnson — $291 million

7. Merck — $285 million

8. Novartis — $254 million

9. AstraZeneca — $225 million

10. Novo Nordisk — $206 million

More articles on supply chain:

4 reasons supply chain managers could one day become CEOs
Can employers lower drug spending by limiting PBM involvement in health plans? 4 thoughts
5 trends shaping today’s supply chain industry

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

  • Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients…

  • Becker’s asked supply chain leaders: If you had an extra $1 million for your supply chain budget, where would it…

  • As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

Advertisement

Comments are closed.